Product Information
CAMRESE LO TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.2436 per EA under NDC 00093614882. Its NADAC has been published 657 times since Nov 28, 2013.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093614882
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Authorized Generic (NDA)
FDA Application
NDA022262On Market Since
12/7/2011
Price Statistics
The NADAC for CAMRESE LO TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 85.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2436 per EA |
|---|---|
| All-time high | $1.9783 (Feb 12, 2014) |
| All-time low | $0.1337 (Jul 17, 2024) |
| 52-week high | $0.2436 |
| 52-week low | $0.1911 |
| Median price | $0.4108 |
| Average price | $0.8766 |
| Largest weekly change | +86.4% (Nov 22, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CAMRESE LO TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CAMRESE LO TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.2436 per EA (NDC 00093614882), effective Jun 24, 2026.
How has the price of CAMRESE LO TABLET changed over time?
Over the history we have for it, the NADAC for CAMRESE LO TABLET has declined 85.8%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CAMRESE LO TABLET?
Since Nov 28, 2013, the NADAC for CAMRESE LO TABLET has ranged from a low of $0.1337 (Jul 17, 2024) to a high of $1.9783 (Feb 12, 2014), with a median of $0.4108 per EA.
Are there cheaper alternatives to CAMRESE LO TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CAMRESE LO TABLET, but none are currently priced below it.
Who manufactures CAMRESE LO TABLET?
CAMRESE LO TABLET (NDC 00093614882) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification